Supplemental Consolidating Data - Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 28, 2021	Mar. 29, 2020
Cash flows from operating activities:
Net income	$ 259,144	$ 69,695
Adjustments to reconcile Net income to Net cash provided (used) by operating activities:
Depreciation and amortization	40,221	47,427
Amortization of deferred loan origination costs	19,200	16,739
Amortization of financing origination fees	3,614	2,999
Provision for long-term employee benefits	7,090	7,852
Employee benefit plan contributions and payments	(9,885)	(1,608)
Stock compensation expense	8,968	3,896
Net change in wholesale finance receivables related to sales	(308,532)	(208,183)
Provision for credit losses	(22,474)	79,419
Deferred income taxes	13,192	(3,803)
Other, net	1,171	3,579
Changes in current assets and liabilities:
Accounts receivable, net	(79,012)	(47,272)
Finance receivables – accrued interest and other	8,947	4,007
Inventories, net	45,086	(23,943)
Accounts payable and accrued liabilities	153,597	10,562
Derivative financial instruments	(3,309)	2,812
Other	25,763	27,240
Total adjustments	(96,363)	(78,277)
Net cash provided (used) by operating activities	162,781	(8,582)
Cash flows from investing activities:
Capital expenditures	(18,813)	(32,928)
Origination of finance receivables	(909,138)	(780,061)
Collections on finance receivables	900,485	841,261
Other investing activities	733	16
Net cash (used) provided by investing activities	(26,733)	28,288
Cash flows from financing activities:
Repayments of medium-term notes	(1,050,000)	(600,000)
Proceeds from securitization debt	597,411	522,694
Repayments of securitization debt	(291,346)	(130,918)
Repayments of asset-backed commercial paper	(66,894)	(67,809)
Net decrease in unsecured commercial paper	(262,517)	772,208
Net increase in credit facilities	15,629	0
Net increase in deposits	72,664	0
Dividends paid	(23,105)	(58,817)
Repurchase of common stock	(5,646)	(7,071)
Issuance of common stock under share-based plans	1,085	34
Net cash (used) provided by financing activities	(1,012,719)	655,508
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(5,163)	(5,732)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period	3,409,168	905,366
Net (decrease) increase in cash, cash equivalents and restricted cash	(881,834)	669,482
Cash, cash equivalents and restricted cash, end of period	2,527,334	$ 1,574,848
HDMC Entities
Cash flows from financing activities:
Proceeds from securitization debt	0
HDFS Entities
Cash flows from financing activities:
Proceeds from securitization debt	597,411
Reportable Legal Entities | HDMC Entities
Cash flows from operating activities:
Net income	169,055
Adjustments to reconcile Net income to Net cash provided (used) by operating activities:
Depreciation and amortization	37,778
Amortization of deferred loan origination costs	0
Amortization of financing origination fees	172
Provision for long-term employee benefits	7,090
Employee benefit plan contributions and payments	(9,885)
Stock compensation expense	8,174
Net change in wholesale finance receivables related to sales	0
Provision for credit losses	0
Deferred income taxes	3,811
Other, net	476
Changes in current assets and liabilities:
Accounts receivable, net	(388,688)
Finance receivables – accrued interest and other	0
Inventories, net	45,086
Accounts payable and accrued liabilities	104,486
Derivative financial instruments	(3,219)
Other	18,222
Total adjustments	(176,497)
Net cash provided (used) by operating activities	(7,442)
Cash flows from investing activities:
Capital expenditures	(18,427)
Origination of finance receivables	0
Collections on finance receivables	0
Other investing activities	733
Net cash (used) provided by investing activities	(17,694)
Cash flows from financing activities:
Repayments of medium-term notes	0
Repayments of securitization debt	0
Repayments of asset-backed commercial paper	0
Net decrease in unsecured commercial paper	0
Net increase in credit facilities	0
Net increase in deposits	0
Dividends paid	(23,105)
Repurchase of common stock	(5,646)
Issuance of common stock under share-based plans	1,085
Net cash (used) provided by financing activities	(27,666)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(5,418)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period	666,161
Net (decrease) increase in cash, cash equivalents and restricted cash	(58,220)
Cash, cash equivalents and restricted cash, end of period	607,941
Reportable Legal Entities | HDFS Entities
Cash flows from operating activities:
Net income	90,010
Adjustments to reconcile Net income to Net cash provided (used) by operating activities:
Depreciation and amortization	2,443
Amortization of deferred loan origination costs	19,200
Amortization of financing origination fees	3,442
Provision for long-term employee benefits	0
Employee benefit plan contributions and payments	0
Stock compensation expense	794
Net change in wholesale finance receivables related to sales	0
Provision for credit losses	(22,474)
Deferred income taxes	9,812
Other, net	775
Changes in current assets and liabilities:
Accounts receivable, net	0
Finance receivables – accrued interest and other	8,947
Inventories, net	0
Accounts payable and accrued liabilities	354,507
Derivative financial instruments	(90)
Other	11,271
Total adjustments	388,627
Net cash provided (used) by operating activities	478,637
Cash flows from investing activities:
Capital expenditures	(386)
Origination of finance receivables	(1,923,911)
Collections on finance receivables	1,606,844
Other investing activities	0
Net cash (used) provided by investing activities	(317,453)
Cash flows from financing activities:
Repayments of medium-term notes	(1,050,000)
Repayments of securitization debt	(291,346)
Repayments of asset-backed commercial paper	(66,894)
Net decrease in unsecured commercial paper	(262,517)
Net increase in credit facilities	15,629
Net increase in deposits	72,664
Dividends paid	0
Repurchase of common stock	0
Issuance of common stock under share-based plans	0
Net cash (used) provided by financing activities	(985,053)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	255
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period	2,743,007
Net (decrease) increase in cash, cash equivalents and restricted cash	(823,614)
Cash, cash equivalents and restricted cash, end of period	1,919,393
Consolidating Adjustments
Cash flows from operating activities:
Net income	79
Adjustments to reconcile Net income to Net cash provided (used) by operating activities:
Depreciation and amortization	0
Amortization of deferred loan origination costs	0
Amortization of financing origination fees	0
Provision for long-term employee benefits	0
Employee benefit plan contributions and payments	0
Stock compensation expense	0
Net change in wholesale finance receivables related to sales	(308,532)
Provision for credit losses	0
Deferred income taxes	(431)
Other, net	(80)
Changes in current assets and liabilities:
Accounts receivable, net	309,676
Finance receivables – accrued interest and other	0
Inventories, net	0
Accounts payable and accrued liabilities	(305,396)
Derivative financial instruments	0
Other	(3,730)
Total adjustments	(308,493)
Net cash provided (used) by operating activities	(308,414)
Cash flows from investing activities:
Capital expenditures	0
Origination of finance receivables	1,014,773
Collections on finance receivables	(706,359)
Other investing activities	0
Net cash (used) provided by investing activities	308,414
Cash flows from financing activities:
Repayments of medium-term notes	0
Proceeds from securitization debt	0
Repayments of securitization debt	0
Repayments of asset-backed commercial paper	0
Net decrease in unsecured commercial paper	0
Net increase in credit facilities	0
Net increase in deposits	0
Dividends paid	0
Repurchase of common stock	0
Issuance of common stock under share-based plans	0
Net cash (used) provided by financing activities	0
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period	0
Net (decrease) increase in cash, cash equivalents and restricted cash	0
Cash, cash equivalents and restricted cash, end of period	$ 0